Compare USA & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | USA | MNKD |
|---|---|---|
| Founded | 1986 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.8B |
| IPO Year | N/A | 2004 |
| Metric | USA | MNKD |
|---|---|---|
| Price | $6.12 | $5.48 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $10.08 |
| AVG Volume (30 Days) | 880.5K | ★ 3.7M |
| Earning Date | 01-01-0001 | 02-25-2026 |
| Dividend Yield | ★ 9.66% | N/A |
| EPS Growth | N/A | ★ 23.47 |
| EPS | N/A | ★ 0.10 |
| Revenue | N/A | ★ $313,787,000.00 |
| Revenue This Year | N/A | $21.40 |
| Revenue Next Year | N/A | $25.03 |
| P/E Ratio | ★ N/A | $55.78 |
| Revenue Growth | N/A | ★ 17.43 |
| 52 Week Low | $5.62 | $3.38 |
| 52 Week High | $7.09 | $6.51 |
| Indicator | USA | MNKD |
|---|---|---|
| Relative Strength Index (RSI) | 38.27 | 46.52 |
| Support Level | $6.22 | $5.03 |
| Resistance Level | $6.33 | $6.05 |
| Average True Range (ATR) | 0.06 | 0.29 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 1.58 | 35.04 |
Liberty All Star Equity Fund is a multi-managed fund. Its objective is to provide a high level of current income and long-term capital appreciation through investing principally in a diversified portfolio of equity securities. The fund invests in various sectors, including financials, information technology, healthcare, consumer discretionary, consumer staples, industrials, energy, materials, real estate, utilities, telecommunication, and other services.
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.